Skip to main content
Year archive

ZELIRA THERAPEUTICS LIMITED — 2019 filings

All 64 regulatory filings released by ZELIRA THERAPEUTICS LIMITED (ZLD) in 2019, sourced directly from the official regulator.

64 Filings
2019 Period
2019 filings (64)
Filing Released Lang
Appendix 3B 14 pages 450.9KB
Capital/Financing Update
2019-12-22 English
Change of Director's Interest Notice x 3 10 pages 313.5KB
Director's Dealing
2019-12-22 English
Last patient completes dosing in insomnia clinical trial 2 pages 141.1KB
Regulatory Filings
2019-12-16 English
Zelira Therapeutics expands HOPE distribution in the U.S.A 2 pages 147.6KB
Capital/Financing Update
2019-12-03 English
Initial Director's Interest Notice x 3 6 pages 176.2KB
Director's Dealing
2019-12-03 English
Official name change to Zelira Therapeutics 2 pages 109.2KB
Regulatory Filings
2019-12-03 English
Ilera Therapeutics Merger Completed and Board Changes 3 pages 172.2KB
Board/Management Information
2019-12-01 English
Final Director's Interest Notice 4 pages 216.3KB
Director's Dealing
2019-12-01 English
Annual General Meeting Presentation 2019 24 pages 6.6MB
AGM Information
2019-11-27 English
2019 AGM Chairman's Address 2 pages 116.1KB
AGM Information
2019-11-27 English
Results of Meeting 2 pages 246.7KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-27 English
New Constitution 44 pages 702.1KB
Governance Information
2019-11-27 English
Investor Presentation - Non-deal Roadshow 27 pages 6.6MB
Investor Presentation
2019-11-24 English
Agreement with Health House to Distribute Zelda Products 3 pages 219.2KB
Regulatory Filings
2019-11-20 English
Update on Global Launch Strategy for HOPE Range of Products 3 pages 143.0KB
Capital/Financing Update
2019-11-19 English
Formulations to be supplied as part of CARE NSW trial 3 pages 167.0KB
Regulatory Filings
2019-11-13 English
R&D Tax Incentive Refund 2 pages 113.3KB
Capital/Financing Update
2019-11-10 English
Zeldas Phase II Insomnia Clinical Trial Fully Enrolled 2 pages 181.5KB
Regulatory Filings
2019-11-06 English
September 2019 Quarterly Report 5 pages 174.0KB
Interim / Quarterly Report
2019-10-30 English
Appendix 4C - quarterly 5 pages 209.6KB
Interim / Quarterly Report
2019-10-30 English
Notice of Annual General Meeting 41 pages 450.9KB
AGM Information
2019-10-24 English
Becoming a substantial holder 3 pages 261.9KB
Regulatory Filings
2019-10-15 English
Zelira Transaction Investor Teleconference and Q&A 4 pages 179.9KB
M&A Activity
2019-10-14 English
Appendix 3B and Cleansing Notice 14 pages 535.5KB
Capital/Financing Update
2019-10-09 English
Zelda to merge with US-based Ilera Therapeutics 6 pages 230.1KB
M&A Activity
2019-10-08 English
Investor Presentation - Zelira - Non Deal Roadshow 25 pages 10.1MB
Investor Presentation
2019-10-08 English
Pause in Trading 1 page 112.4KB
Regulatory Filings
2019-10-07 English
Trading Halt 3 pages 420.5KB
Regulatory Filings
2019-10-07 English
Appendix 3B 13 pages 381.9KB
Share Issue/Capital Change
2019-09-26 English
Cancellation of Unlisted Options 2 pages 162.1KB
Share Issue/Capital Change
2019-09-01 English
Appendix 4E & Financial Statements 67 pages 1.5MB
Annual Report
2019-08-29 English
Appendix 4G 10 pages 170.1KB
Governance Information
2019-08-29 English
Zeldas Autism Observational Study Recruits 100th Participant 3 pages 140.7KB
Regulatory Filings
2019-08-21 English
Appendix 4C - quarterly 5 pages 209.2KB
Interim / Quarterly Report
2019-07-30 English
June 2019 Quarterly Report 3 pages 159.7KB
Interim / Quarterly Report
2019-07-30 English
US Non-deal Roadshow - Investor Presentation 28 pages 12.5MB
Investor Presentation
2019-07-21 English
Appendix 3B and Cleansing Notice - Exercise of Options 14 pages 529.8KB
Capital/Financing Update
2019-07-18 English
Zelda Collaborates with Emerald Clinics 3 pages 174.4KB
Regulatory Filings
2019-07-17 English
Response to ASX Price and Volume Query 6 pages 309.6KB
Regulatory Filings
2019-07-10 English
Investor Presentation - Non-deal Roadshow 28 pages 10.2MB
Investor Presentation
2019-07-09 English
Zelda Granted Approval for Opioid Reduction Trial 2 pages 173.2KB
Regulatory Filings
2019-07-01 English
Director Shareholding Changes and Strategic Investment 2 pages 166.6KB
Director's Dealing
2019-06-10 English
Change of Director's Interest Notice x 3 7 pages 242.0KB
Director's Dealing
2019-06-10 English
Change in substantial holding 3 pages 126.3KB
Major Shareholding Notification
2019-06-10 English
Investor Presentation - Non-deal Roadshow 17 pages 12.0MB
Investor Presentation
2019-05-12 English
R&D Tax Incentive Refund 1 page 141.3KB
Regulatory Filings
2019-05-08 English
March 2019 Quarterly Report 4 pages 125.7KB
Interim / Quarterly Report
2019-04-29 English
Appendix 4C - quarterly 5 pages 184.1KB
Interim / Quarterly Report
2019-04-29 English
Zelda Partners with Ilera HealthCare 2 pages 180.2KB
Capital/Financing Update
2019-03-11 English
Aus Patent For Novel Prognostic Marker for Breast Cancer 2 pages 181.3KB
Regulatory Filings
2019-03-05 English
Novel Cannabis Pathway for Treatment of Breast Cancer 2 pages 201.3KB
Regulatory Filings
2019-02-27 English
Appendix 4D & FY19 Interim Financial Report 21 pages 1.1MB
Interim / Quarterly Report
2019-02-21 English
Appendix 3B 13 pages 353.3KB
Capital/Financing Update
2019-02-18 English
Results of Meeting 2 pages 185.3KB
Declaration of Voting Results & Voting Rights Announcements
2019-02-17 English
ZLD Engages ICCI for Clinical Trial and Regulatory Expertise 2 pages 184.2KB
Regulatory Filings
2019-02-11 English
Change of Director's Interest Notice 3 pages 193.1KB
Director's Dealing
2019-02-04 English
December 2018 Quarterly Report and Board Transition 3 pages 212.2KB
Interim / Quarterly Report
2019-01-29 English
Appendix 4C - quarterly 5 pages 175.9KB
Interim / Quarterly Report
2019-01-29 English
Notice of General Meeting 9 pages 159.5KB
Proxy Solicitation & Information Statement
2019-01-17 English
Response to ASX Appendix 3Y Query 4 pages 309.4KB
Director's Dealing
2019-01-15 English
Appendix 3B 14 pages 356.4KB
Capital/Financing Update
2019-01-15 English
Change of Director's Interest Notice 3 pages 191.9KB
Director's Dealing
2019-01-13 English
Change in substantial holding 2 pages 146.5KB
Major Shareholding Notification
2019-01-13 English
Response to ASX Price and Volume Query 5 pages 306.2KB
Regulatory Filings
2019-01-07 English